• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 22, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

US public companies have increasingly shorter lifespans, IU research says

Bioengineer by Bioengineer
April 11, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

BLOOMINGTON, Ind. — At a time when more Americans are living longer, the companies where many people spend their working lives have increasingly shorter lifespans, according to research from Indiana University's Kelley School of Business.

A paper by two Kelley professors, forthcoming in the Academy of Management Annals, found that the odds of a company surviving more than five years has declined dramatically since the 1960s and that this trend also holds for firms lasting 10, 15 and 20 years.

Companies emerging as publicly listed firms in the 1960s had a 50-50 shot of making it to their 20-year anniversary. By the 1990s, that percentage fell to 20 percent. Similarly, such companies used to have an 80 percent chance of being around after 10 years, but those odds were down to 50 percent for firms established after 2000.

These findings are based on an empirical analysis of nearly 32,000 U.S. publicly listed companies between 1960 and 2015 by Rene Bakker, assistant professor of management and entrepreneurship, and Matthew Josefy, assistant professor of strategy and entrepreneurship.

The researchers believe that long-held views about the age of companies have changed as organizations have become increasingly temporary in nature. Research on firm age dates back to the mid-1960s, but little has been done since the early 1990s. Bakker and Josefy question whether firm age today is anything more than a number and suggest that it may no longer predict organizational success.

"We believe this trend reflects an important shift in our understanding of the very DNA of what constitutes an organization," the researchers wrote. "Short-lived, temporary organizations that rapidly accomplish a complex task and disband on its accomplishment are increasingly common across a broad range of industries."

In the previous century, many businesses were run with the expectation that they'd be taken over by the next generation of a family.

"The history of American businesses was centered around these family enterprises," Josefy said. "The whole reason of incorporating was so the organization would live longer than the founder, giving them a sense of immortality. Here's the irony: These large corporations aren't even going to live as long as the founder, much less get passed down to the next generation of owners."

Classic management theory suggests that firm age is positively associated with learning, reliability and legitimacy. But today it may have more negative connotations in certain contexts, such as the tech sector, which rewards novelty and youthfulness.

In their paper, Bakker and Josefy raise the question of whether the American corporation is becoming more disposable, reflecting the temporary nature of other aspects of our society. They suspect that the diminishing lifespan of U.S. companies is partly due to more active merger and acquisition activity in recent years. But they also attribute it to a culture that encourages start-ups.

"We live in an environment where starting and liquidating a business is quite easy," Bakker said. "Many young firms today seem destined to become 'organizational supernovas,' which burn brighter but die quicker."

Once a start-up reaches its desired objectives, it may be acquired or morph into another entity with new goals.

"While society is often concerned to see businesses fail, sometimes it may be better for a company to die to free up resources and allow people to go on and do something else, rather than persist with uncertainty and stagnation," Josefy said. "Apparent failure of one entity may actually be the precursor to success of another."

###

Editors: Contact George Vlahakis at [email protected] or 812-855-0846 for a copy of Bakker and Josefy's paper, "More Than Just a Number? The Conceptualization and Measurement of Firm Age in an Era of Temporary Organizations."

Media Contact

George Vlahakis
[email protected]
812-855-0846
@IUScienceNews

http://newsinfo.iu.edu

Share13Tweet7Share2ShareShareShare1

Related Posts

Study Finds No Link Between Animal Protein Consumption and Increased Mortality Risk

Study Finds No Link Between Animal Protein Consumption and Increased Mortality Risk

August 22, 2025
Blocking MondoA–TXNIP Boosts Immunity Against Tumors

Blocking MondoA–TXNIP Boosts Immunity Against Tumors

August 22, 2025

Lymph Node Subtypes Reveal Colorectal Cancer Insights

August 22, 2025

CrAAVe-seq reveals key neuronal genes in vivo

August 22, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Signaling Pathways Drive Cisplatin Resistance via SOX2

Study Finds No Link Between Animal Protein Consumption and Increased Mortality Risk

Ovarian Cancer Trends in War-Torn Syria

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.